Speaker

Fredrik Frejd

Chief Scientific Officer & Vice President - Research, Affibody AB

Fredrik Frejd, Chief Scientific Officer & Vice President - Research at Affibody AB, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “Expanding Radiopharmaceuticals Beyond Established Indications Through Engineered Scaffold Proteins”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

8th Targeted Radiopharmaceuticals Summit Europe 2026
1–3 Dec 2026London, United Kingdom
- SpeakerExpanding Radiopharmaceuticals Beyond Established Indications Through Engineered Scaffold Proteins

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Fredrik Frejd, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].